Restless legs syndrome (RLS) is more than just fidgeting—it’s a neurological condition that can rob you of restful sleep. It ...
May 26, 2005 (Atlanta) — As the result of positive phase 3 trials, ropinirole (Requip) has been approved for the treatment of restless legs syndrome (RLS). The data presented here at the 2005 American ...
Restless leg syndrome (RLS) is often worse at nighttime. Some people may only have the symptoms at this time. Many with RLS also experience limb movements during sleep. As many as 80% of people with ...
Restless legs syndrome (RLS) is a sleep disorder that causes a feeling of heaviness and discomfort in the legs, usually after going to bed. Stretching or moving the legs usually helps. It may also ...
A growing body of research has highlighted a strong association between chronic kidney disease (CKD) and Restless Legs Syndrome (RLS), a neurological condition that significantly affects sleep and ...
PLEASANTON, Calif., April 19, 2023 /PRNewswire/ -- Noctrix Health announced that the U.S. Food and Drug Administration (FDA) has granted its De Novo request for the NTX100 Tonic Motor Activation ...
Treatment of restless legs syndrome (RLS) usually involves dopamine agonists, which are approved for treatment of RLS in most countries; α-2-δ ligands, such as gabapentin enacarbil and pregabalin, are ...